Upgrade Watch: Names that are Leaping into Focus

October 6, 2025

DENVER, Colo., Oct 06, 2025 (247marketnews.com)- Wall Street’s upgrade engine is kicking into gear; these companies are among those getting fresh optimism and each offers a different pathway for investors.

Society Pass (NASDAQ:SOPA) was the subject of a bullish research upgrade by Ascendiant Capital Markets, which raised its 12‑month target to $18 (from $15). The note highlighted 46% year-over-year revenue growth, unexpectedly positive Q2 EPS ($0.10 vs. estimates of –$0.24), and a massive disconnect between its ~$5M market cap and $29M in cash, not to mention a controlling stake in NusaTrip (NASDAQ:NUTR).

Ascendiant calls it “high risk, high reward,” but positions SOPA as deeply undervalued relative to its $29 million in cash and massive disconnect between its current $5 million market cap and the estimated $100 million value of its NusaTrip stake (NASDAQ:NUTR), now trading around $8.00. With another IPO on the horizon and multiple e-commerce properties under development.

VENU (NYSE:VENU) is continuing its run as one of the market’s most exciting experiential real estate stories. Fresh off its Pollstar-nominated Ford Amphitheater’s packed Miranda Lambert benefit concert, VENU is proving its vertically integrated model is more than hype. The event—supporting the Air Force Academy Athletic Corporation, brought in one of the venue’s largest crowds ever, and showcased the platform’s unique ability to fuse live entertainment, community impact, and real estate value creation.

With construction on $1.3 billion in new projects and a target of 40 venues by 2030, VENU is not just throwing concerts, it’s creating an entirely new asset class. Analysts at ThinkEquity raised their price target to $18, calling VENU the “blueprint for a new asset class” in experiential real estate, while Cenorium has a $22.30 price target.

Micron Technology (NASDAQ:MU) is riding a wave of bullishness after Morgan Stanley upgraded MU from “Equal‑Weight” to “Overweight”, raising its price target from $160 to $220. The firm pointed to sustained demand for DRAM and NAND memory in AI, data center, and high-performance workloads as key drivers.

Micron shares jumped on the news, touching a session high above $200. With memory cycles notoriously volatile, though, investors should watch closely for confirmation of demand and margin trends into FY2026.

Guggenheim upgraded Johnson & Johnson (NYSE:JNJ) from “Neutral” to “Buy” and raised its target to $206 from $167. The case: J&J’s newly launched and pipeline medicines, such as Tremfya, Darzalex, and Caplyta, aren’t fully valued, and its ability to manage patent expirations gives further upside.

For income-oriented and large-cap portfolios, JNJ may now look more attractive, especially if it can show renewed growth in its pharma and medical devices segments.

Cloud and big data infrastructure continue to garner attention: Capital One upgraded Snowflake (NYSE:SNOW) to “Buy” with a ~$195 price target, citing stabilization in revenue trends and momentum in its AI-enabled platform initiatives. Other analysts have also flagged the acceleration in ARR as a compelling element in the re-rating narrative.

With cloud workloads increasingly moving toward AI inference and hybrid architectures, Snowflake is seen by some as well placed to benefit from next‑gen data demand.

Arteris (NASDAQ:AIP) is quietly approaching average analyst price target of $14, so it may appear on more analysts’ radars as semiconductor and AI infrastructure plays deepen. The company designs on-chip interconnect IP, critical for complex AI SoCs and automotive processors. In a world pushing more compute into edge, every design node and interconnect block matters. Given the broader upgrade momentum around chip and AI infrastructure names (e.g. Micron), AIP could be a sleeper pick in the semi / IP supply chain space.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For the full 24/7 Market News VENU report and in-depth insights, visit: Read 24/7 Market News VENU Report/

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (VENU, SOPA, MU, AIP, SNOW, JNJ)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.